论文部分内容阅读
目的:对布地奈德联合沙丁胺醇雾化吸入治疗急性加重期慢性阻塞性肺疾病患者(AECOPD)效果进行观察。方法:将我院2014年3月至2015年3月间收治的AECOPD患者70例作为研究对象,并分为观察组35例及对照组35例。对照组在常规治疗基础上给予沙丁胺醇雾化吸入治疗,观察组在常规治疗基础上给予布地奈德联合沙丁胺醇雾化吸入治疗,对比两组患者治疗效果。结果:观察组总有效率为94.29%;对照组总有效率为82.86%。观察组总有效率要高于对照组(P<0.05)。结论:布地奈德联合沙丁胺醇雾化吸入治疗AECOPD具有较好的效果,可有效控制患者病情,改善患者肺功能。
OBJECTIVE: To observe the effect of budesonide combined with albuterol inhalation on patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods: Seventy patients with AECOPD admitted to our hospital from March 2014 to March 2015 were selected as study subjects and divided into observation group (35 cases) and control group (35 cases). The control group was given inhalation of salbutamol inhalation on the basis of conventional treatment. The observation group was treated with inhalation of budesonide combined with salbutamol inhalation on the basis of routine treatment, and the therapeutic effect was compared between the two groups. Results: The total effective rate was 94.29% in the observation group and 82.86% in the control group. The total effective rate in observation group was higher than that in control group (P <0.05). Conclusion: Budesonide combined with salbutamol nebulization for AECOPD has a good effect, which can effectively control the patient’s condition and improve the lung function.